Total Payments
$38,328
2024 Payments
$520.04
Companies
27
Transactions
187
Medicare Patients
3,217
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$34,216 (89.3%)
Food & Beverage$2,940 (7.7%)
Travel$801.45 (2.1%)
Education$370.02 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,216 | 22 | 89.3% |
| Food and Beverage | $2,940 | 147 | 7.7% |
| Travel and Lodging | $801.45 | 9 | 2.1% |
| Education | $370.02 | 9 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $20,870 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $15,104 | 38 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $330.85 | 12 | $0 (2021) |
| Fresenius USA Marketing, Inc. | $231.47 | 13 | $0 (2024) |
| Amgen Inc. | $226.35 | 13 | $0 (2022) |
| Relypsa, Inc. | $188.35 | 10 | $0 (2020) |
| Daiichi Sankyo Inc. | $175.78 | 11 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $164.25 | 10 | $0 (2024) |
| Travere Therapeutics, Inc. | $153.86 | 9 | $0 (2024) |
| Kyowa Kirin, Inc. | $147.35 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $520.04 | 19 | Kyowa Kirin, Inc. ($147.35) |
| 2023 | $348.49 | 19 | Travere Therapeutics, Inc. ($93.82) |
| 2022 | $22,752 | 46 | Bayer HealthCare Pharmaceuticals Inc. ($20,814) |
| 2021 | $11,155 | 33 | AstraZeneca Pharmaceuticals LP ($10,904) |
| 2020 | $2,922 | 33 | AstraZeneca Pharmaceuticals LP ($2,421) |
| 2019 | $117.28 | 4 | AstraZeneca Pharmaceuticals LP ($88.97) |
| 2018 | $67.72 | 4 | Relypsa, Inc. ($25.05) |
| 2017 | $444.44 | 29 | Relypsa, Inc. ($104.52) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: GENETIC DISEASE | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: GENETIC DISEASE | ||||||
| 09/24/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/17/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.78 | General |
| 09/10/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/21/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/23/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/27/2024 | Kyowa Kirin, Inc. | — | Food and Beverage | In-kind items and services | $123.55 | General |
| 06/25/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $19.47 | General |
| 06/18/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 06/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: IMMUNOLOGY | ||||||
| 05/21/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/26/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Iron Deficiency Anemia | ||||||
| 02/21/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $22.20 | General |
| 02/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Cardio-renal | ||||||
| 01/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/22/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $22.03 | General |
| 12/11/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Hyperkalemia | ||||||
| 11/28/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.79 | General |
| 11/17/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 630 | 2,357 | $456,375 | $258,714 |
| 2022 | 9 | 590 | 2,345 | $447,398 | $250,874 |
| 2021 | 10 | 578 | 2,124 | $444,956 | $253,064 |
| 2020 | 16 | 1,419 | 3,932 | $797,126 | $337,481 |
Total Patients
3,217
Total Services
10,758
Medicare Billing
$1.1M
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 57 | 448 | $224,000 | $128,177 | 57.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 222 | 1,061 | $106,100 | $66,644 | 62.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 183 | 290 | $58,000 | $29,788 | 51.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 44 | 82 | $32,800 | $19,793 | 60.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 78 | $11,700 | $7,395 | 63.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 40 | 48 | $12,000 | $2,730 | 22.8% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 23 | 325 | $5,525 | $2,474 | 44.8% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 11 | 25 | $6,250 | $1,713 | 27.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 59 | 432 | $216,000 | $124,024 | 57.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 187 | 937 | $93,700 | $53,492 | 57.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 171 | 246 | $49,200 | $26,428 | 53.7% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 12 | 84 | $37,800 | $20,455 | 54.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 73 | 126 | $18,900 | $10,384 | 54.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 20 | 35 | $14,000 | $8,592 | 61.4% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 31 | 444 | $7,548 | $3,491 | 46.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $4,000 | $2,541 | 63.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 21 | 25 | $6,250 | $1,466 | 23.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 55 | 467 | $233,500 | $138,226 | 59.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 187 | 759 | $75,900 | $44,238 | 58.3% |
| 90966 | Home dialysis services per month, patient 20 years of age or older | Office | 2021 | 12 | 91 | $40,950 | $22,943 | 56.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 148 | 198 | $39,600 | $21,697 | 54.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 88 | 145 | $21,750 | $12,059 | 55.4% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 12 | 20 | $8,000 | $4,910 | 61.4% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2021 | 23 | 368 | $6,256 | $2,944 | 47.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 29 | 40 | $10,000 | $2,388 | 23.9% |
About Dr. Muhammad Bashir, MD
Dr. Muhammad Bashir, MD is a Nephrology healthcare provider based in Chico, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1720081342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Bashir, MD has received a total of $38,328 in payments from pharmaceutical and medical device companies, with $520.04 received in 2024. These payments were reported across 187 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,216).
As a Medicare-enrolled provider, Bashir has provided services to 3,217 Medicare beneficiaries, totaling 10,758 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Chico, CA
- Active Since 05/27/2005
- Last Updated 04/17/2009
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1720081342
Products in Payments
- Kerendia (Drug) $20,870
- LOKELMA (Drug) $15,034
- JYNARQUE (Drug) $330.85
- Veltassa (Drug) $227.98
- Parsabiv (Drug) $201.10
- ACTHAR (Biological) $182.25
- INJECTAFER (Drug) $175.78
- LUPKYNIS (Drug) $164.25
- Velphoro (Drug) $131.82
- SOLIRIS (Drug) $67.14
- BENLYSTA (Biological) $64.04
- Not Product Related (Medical Supply) $55.42
- TAKHZYRO (Biological) $53.13
- FARXIGA (Drug) $51.65
- Rayaldee (Drug) $42.46
- Uloric (Drug) $29.59
- LINZESS (Drug) $27.06
- Fabhalta (Drug) $26.48
- PREVNAR 13 (Biological) $26.03
- Parsabiv (Biological) $25.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chico
Dr. Jose Sibal, M.d, M.D
Nephrology — Payments: $6,772
Nephrology $6,772
Mona Sarbu, Md, MD
Nephrology — Payments: $2,024
Nephrology $2,024
Nasrin Ashouian, Md, MD
Nephrology — Payments: $598.78
Nephrology $598.78
Dr. Nadine Tanenbaum, Md, MD
Nephrology
Nephrology
Dr. Arisara Suwangomolkul, M.d, M.D
Nephrology
Nephrology